Ethan R. Goldman
Lawyers
Filters
Far Peak Acquisition $550 million IPO
Davis Polk advised the sole underwriter in connection with the $550 million initial public offering of 55,000,000 units of Far Peak Acquisition Corporation. Each unit consists of one…
Bertelsmann $2.175 billion acquisition of Simon & Schuster
Davis Polk is advising Bertelsmann on the $2.175 billion acquisition by its global trade book publishing group, Penguin Random House, of Simon & Schuster from ViacomCBS. The transaction…
AlphaFlow Series A equity financing
Davis Polk advised AlphaFlow Inc. in connection with a Series A round of financing led by Saluda Grade Ventures, Y Combinator, 10X Capital, Resolute Ventures, Upside Partnership, Vishal…
BioNTech $500 million SEC-registered at-the-market offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by BioNTech SE of its ordinary shares represented by American depositary shares for up to an…
Finance of America Funding $350 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Finance of America Funding LLC of $350 million aggregate…
Allegro MicroSystems $402.5 million IPO
Davis Polk advised the representatives of the underwriters in connection with the $402.5 million initial public offering of 28,750,000 shares of common stock by Allegro MicroSystems,…
MediaAlpha $175.8 million IPO
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $175.8 million initial public offering of 10,637,500 shares of Class A…
MultiPlan $1.3 billion senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by MPH Acquisition Holdings LLC, a wholly owned subsidiary of MultiPlan…
Turning Point Therapeutics $460 million stock offering
Davis Polk advised the joint book-running managers in connection with a $460 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…
Track & Field R$454.8 million IPO
Davis Polk advised Track & Field Co S.A. and the selling shareholders in connection with Track & Field’s initial public offering of 49,166,000 preferred shares for an aggregate…